1492 Capital Management LLC Has $4.67 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

1492 Capital Management LLC raised its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 16.5% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 52,884 shares of the company's stock after acquiring an additional 7,490 shares during the quarter. HealthEquity accounts for about 2.5% of 1492 Capital Management LLC's portfolio, making the stock its 12th biggest holding. 1492 Capital Management LLC owned 0.06% of HealthEquity worth $4,673,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently bought and sold shares of the business. Transce3nd LLC acquired a new position in shares of HealthEquity in the 4th quarter valued at about $29,000. Versant Capital Management Inc acquired a new position in shares of HealthEquity in the 1st quarter valued at about $28,000. Larson Financial Group LLC increased its holdings in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after purchasing an additional 642 shares during the period. Huntington National Bank increased its holdings in HealthEquity by 89.4% in the fourth quarter. Huntington National Bank now owns 767 shares of the company's stock worth $74,000 after buying an additional 362 shares during the last quarter. Finally, Whipplewood Advisors LLC increased its holdings in HealthEquity by 5,060.0% in the first quarter. Whipplewood Advisors LLC now owns 774 shares of the company's stock worth $68,000 after buying an additional 759 shares during the last quarter. 99.55% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

HQY has been the topic of a number of research reports. KeyCorp dropped their price objective on HealthEquity from $110.00 to $100.00 and set an "overweight" rating on the stock in a report on Wednesday, April 16th. Deutsche Bank Aktiengesellschaft increased their price objective on HealthEquity from $98.00 to $115.00 and gave the stock a "buy" rating in a report on Thursday, June 5th. Royal Bank Of Canada increased their price target on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a report on Wednesday, June 4th. Barrington Research increased their price target on HealthEquity from $112.00 to $125.00 and gave the company an "outperform" rating in a report on Thursday, June 5th. Finally, JMP Securities increased their price target on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a report on Wednesday, June 4th. One investment analyst has rated the stock with a hold rating, ten have issued a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Buy" and a consensus price target of $118.55.

HealthEquity Stock Up 1.8%

NASDAQ HQY traded up $1.66 during trading on Friday, hitting $96.04. The stock had a trading volume of 497,345 shares, compared to its average volume of 863,282. The company has a market capitalization of $8.30 billion, a PE ratio of 70.10, a P/E/G ratio of 1.49 and a beta of 0.49. The company's 50-day moving average price is $101.54 and its two-hundred day moving average price is $98.42. The company has a debt-to-equity ratio of 0.50, a quick ratio of 4.06 and a current ratio of 4.06. HealthEquity, Inc. has a 12 month low of $65.01 and a 12 month high of $116.65.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, June 3rd. The company reported $0.97 earnings per share for the quarter, topping the consensus estimate of $0.81 by $0.16. The firm had revenue of $330.80 million for the quarter, compared to analyst estimates of $322.25 million. HealthEquity had a return on equity of 11.01% and a net margin of 9.80%. During the same quarter in the previous year, the firm earned $0.80 EPS. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In related news, Director Jon Kessler sold 134,183 shares of the business's stock in a transaction that occurred on Friday, June 6th. The stock was sold at an average price of $112.08, for a total transaction of $15,039,230.64. Following the transaction, the director directly owned 253,510 shares of the company's stock, valued at approximately $28,413,400.80. The trade was a 34.61% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael Henry Fiore sold 1,794 shares of the firm's stock in a transaction on Monday, July 7th. The shares were sold at an average price of $101.73, for a total value of $182,503.62. Following the sale, the executive vice president directly owned 53,225 shares of the company's stock, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 291,744 shares of company stock valued at $32,705,007 in the last 90 days. 1.50% of the stock is currently owned by insiders.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.